Takeda Pharmaceutical (TAK) Operating Expenses (2017 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Operating Expenses of -$2.8 billion for Q2 2026, down 53.58% year-over-year from -$6.1 billion in Q2 2025, and down 55.88% quarter-over-quarter from -$1.8 billion in Q1 2026.
Takeda Pharmaceutical (TAK) Operating Expenses (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Operating Expenses history runs 10 years deep, the most recent figure standing at -$2.8 billion for Q2 2026.
- In Q2 2026, Operating Expenses fell 53.58% year-over-year to -$2.8 billion; the TTM figure through Jun 2026 stood at -$12.1 billion (down 9.95% YoY), while the FY2026 annual figure was -$1.9 billion, down 7.38% from the prior year.
- Operating Expenses for Q2 2026 stood at -$2.8 billion, down from -$1.8 billion in the prior quarter.
- The five-year high for Operating Expenses was -$1.7 billion in Q2 2024, with the low at -$5.5 billion in Q3 2025.
- The 5-year median for Operating Expenses is -$1.9 billion (2022), against an average of -$2.8 billion.
- Peak annual rise in Operating Expenses reached 42.97% in 2022, while the deepest fall reached 123.06% in 2022.
- Takeda Pharmaceutical's Operating Expenses stood at -$1.8 billion in 2022, then decreased by 6.98% to -$1.9 billion in 2023, then decreased by 0.88% to -$1.9 billion in 2024, then grew by 1.21% to -$1.9 billion in 2025, then sank by 48.11% to -$2.8 billion in 2026.
- Business Quant data shows TAK's Operating Expenses at -$2.8 billion in Q2 2026, -$1.8 billion in Q1 2026, and -$1.9 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.75 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.22 Bn | 39.57 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.40 Bn | 29.72 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.61 Bn | 15.22 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.96 Bn | 11.43 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.08 Bn | 9.91 Bn | - | - |
| 10 | Alkermes | 8.25 Bn | 7.60 Bn | 397.90 Mn | 477.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.85 Bn |
| Mar 31, 2026 | -1.83 Bn |
| Dec 31, 2025 | -1.92 Bn |
| Sep 30, 2025 | -5.49 Bn |
| Jun 30, 2025 | -1.85 Bn |
| Mar 31, 2025 | -1.77 Bn |
| Dec 31, 2024 | -1.95 Bn |
| Sep 30, 2024 | -5.42 Bn |
| Jun 30, 2024 | -1.72 Bn |
| Mar 31, 2024 | -1.82 Bn |
| Dec 31, 2023 | -1.93 Bn |
| Sep 30, 2023 | -5.32 Bn |
| Jun 30, 2023 | -1.85 Bn |
| Mar 31, 2023 | -1.88 Bn |
| Dec 31, 2022 | -1.80 Bn |
| Sep 30, 2022 | -5.38 Bn |
| Jun 30, 2022 | -1.92 Bn |
| Mar 31, 2022 | -3.23 Bn |
| Dec 31, 2021 | -3.16 Bn |
| Sep 30, 2021 | -3.12 Bn |